OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors
Ali Vaziri‐Gohar, Joel Cassel, Farheen S. Mohammed, et al.
Nature Cancer (2022) Vol. 3, Iss. 7, pp. 852-865
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

The pentose phosphate pathway in health and disease
Tara TeSlaa, Markus Ralser, Jing Fan, et al.
Nature Metabolism (2023) Vol. 5, Iss. 8, pp. 1275-1289
Open Access | Times Cited: 171

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
Yan-Ruide Li, Ying Fang, Shaoqiang Niu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2

Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies
Yu Zhang, Chengzhong Lin, Zheqi Liu, et al.
Cell Metabolism (2022) Vol. 34, Iss. 12, pp. 1999-2017.e10
Open Access | Times Cited: 68

In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma
Akash Kaushik, Amy Tarangelo, Lindsey K. Boroughs, et al.
Science Advances (2022) Vol. 8, Iss. 50
Open Access | Times Cited: 38

Targeting the RNA-Binding Protein HuR in Cancer
Jennifer M. Finan, Thomas L. Sutton, Dan A. Dixon, et al.
Cancer Research (2023) Vol. 83, Iss. 21, pp. 3507-3516
Closed Access | Times Cited: 22

Lactate enhances NMNAT1 lactylation to sustain nuclear NAD+ salvage pathway and promote survival of pancreatic adenocarcinoma cells under glucose-deprived conditions
Huimin Huang, Shitong Wang, Hongping Xia, et al.
Cancer Letters (2024) Vol. 588, pp. 216806-216806
Closed Access | Times Cited: 9

Precision treatment of pancreatic ductal adenocarcinoma
Hongyun Wei, He Ren
Cancer Letters (2024) Vol. 585, pp. 216636-216636
Closed Access | Times Cited: 8

BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma
Chengheng Liao, Lianxin Hu, Liwei Jia, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Increased glucose availability sensitizes pancreatic cancer to chemotherapy
Ali Vaziri‐Gohar, Jonathan J. Hue, Ata Abbas, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20

Scutellarin activates IDH1 to exert antitumor effects in hepatocellular carcinoma progression
Zhao Cui, Caifeng Li, Wei Liu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 7

Photoactivated Gas-Generating Nanocontrast Agents for Long-Term Ultrasonic Imaging-Guided Combined Therapy of Tumors
Binbin Chu, Zhiming Chen, Xiaofeng Wu, et al.
ACS Nano (2024) Vol. 18, Iss. 24, pp. 15590-15606
Closed Access | Times Cited: 7

The Cancer Antioxidant Regulation System in Therapeutic Resistance
Xuanhao Gu, Chunyang Mu, Rujia Zheng, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 778-778
Open Access | Times Cited: 6

The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer
Yang Liu, Wei Xu, Mingxue Li, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 4, pp. 1438-1466
Open Access | Times Cited: 13

αKG-mediated carnitine synthesis promotes homologous recombination via histone acetylation
Apoorva Uboveja, Zhentai Huang, Raquel Buj, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5

Nanoparticles for inducing Gaucher disease-like damage in cancer cells
Chunyan Yue, Wenjing Lu, Shuxin Fan, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 8, pp. 1203-1215
Closed Access | Times Cited: 5

CAR-T Cell Therapy for Solid Tumors
Liz T. Tony, Andrea Stabile, Marc Philipp Schauer, et al.
Transfusion Medicine and Hemotherapy (2025), pp. 1-13
Open Access

Unraveling the Connection Between Ion Channels and Pancreatic Stellate Cell Activation
Julie Auwercx, Mathilde Fourgeaud, Alexis Lalot, et al.
Cellular Physiology and Biochemistry (2025) Vol. 59, Iss. S1, pp. 25-40
Open Access

Weight Management for Fertility-Preservation Therapy in Endometrial Cancer: Opportunities and Challenges
Xiaodan Li, YiQian Chen, Xiaowei Li, et al.
Current Oncology Reports (2025)
Closed Access

Role of malate dehydrogenase 1 and isocitrate dehydrogenase 1 and their posttranslational modifications in diseases
Chunxia Shi, Yukun Wang, Jin Guo, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 754, pp. 151535-151535
Closed Access

Loss of fatty acid-binding protein 7 promotes B16F10 melanoma metastasis
Tunyanat Wannakul, Hirofumi Miyazaki, Motoko Maekawa, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

IDH1 inhibition potentiates chemotherapy efficacy in pancreatic cancer
Mehrdad Zarei, Omid Hajihassani, Jonathan J. Hue, et al.
Cancer Research (2024)
Open Access | Times Cited: 4

Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies
Zhiqin Wang, Bowen Wu, Guangjun Nie, et al.
Cancer Letters (2023) Vol. 560, pp. 216138-216138
Closed Access | Times Cited: 9

Lysosomal alkalinization in nutrient restricted cancer cells activates cytoskeletal rearrangement to enhance partial epithelial to mesenchymal transition
Hepşen Hazal Hüsnügil, Aliye Ezgi Güleç Taşkıran, İsmail Güderer, et al.
Translational Oncology (2024) Vol. 41, pp. 101860-101860
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top